Advertisement

 

 

Genomic Hallmarks of Thyroid Neoplasia.

Genomic Hallmarks of Thyroid Neoplasia.
Author Information (click to view)

Giordano TJ,


Giordano TJ, (click to view)

Giordano TJ,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Annual review of pathology 2017 10 30() doi 10.1146/annurev-pathol-121808-102139

Abstract

The genomic landscape of thyroid cancers that are derived from follicular cells has been substantially elucidated through the coordinated application of high-throughput genomic technologies. Here, I review the common genetic alterations across the spectrum of thyroid neoplasia and present the resulting model of thyroid cancer initiation and progression. This model illustrates the striking correlation between tumor differentiation and overall somatic mutational burden, which also likely explains the highly variable clinical behavior and outcome of patients with thyroid cancers. These advances are yielding critical insights into thyroid cancer pathogenesis, which are being leveraged for the development of new diagnostic tools, prognostic and predictive biomarkers, and novel therapeutic approaches Expected final online publication date for the Annual Review of Pathology: Mechanisms of Disease Volume 13 is January 24, 2018. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

Submit a Comment

Your email address will not be published. Required fields are marked *

7 + six =

[ HIDE/SHOW ]